Tumors of mesenchymal origin, such as osteosarcomas and rhabdomyosarcomas that physiologically express HGF, can acquire an aberrant expression of MET leading to the establishment of an autocrine loop that sustains constitutive activation of the signaling pathway [56]. Here, MET is linked to osteosarcoma.